Natera Basic EPS 2014-2025 | NTRA
- Natera basic eps for the quarter ending March 31, 2025 was $-0.50, a 10.71% decline year-over-year.
- Natera basic eps for the twelve months ending March 31, 2025 was $-1.47, a 52.73% decline year-over-year.
- Natera annual basic eps for 2024 was $-0.002B, a 59.52% decline from 2023.
- Natera annual basic eps for 2023 was $-0.004B, a 32.14% decline from 2022.
- Natera annual basic eps for 2022 was $-0.006B, a 6.91% increase from 2021.
Natera Annual Basic EPS | |
---|---|
2024 | $-1.53 |
2023 | $-3.78 |
2022 | $-5.57 |
2021 | $-5.21 |
2020 | $-2.84 |
2019 | $-1.79 |
2018 | $-2.22 |
2017 | $-2.58 |
2016 | $-1.95 |
2015 | $-2.68 |
2014 | $-1.07 |
2013 | $-9.66 |
Natera Quarterly Basic EPS | |
---|---|
2025-03-31 | $-0.50 |
2024-12-31 | $-0.41 |
2024-09-30 | $-0.26 |
2024-06-30 | $-0.30 |
2024-03-31 | $-0.56 |
2023-12-31 | $-0.63 |
2023-09-30 | $-0.95 |
2023-06-30 | $-0.97 |
2023-03-31 | $-1.23 |
2022-12-31 | $-1.37 |
2022-09-30 | $-1.25 |
2022-06-30 | $-1.50 |
2022-03-31 | $-1.45 |
2021-12-31 | $-1.52 |
2021-09-30 | $-1.63 |
2021-06-30 | $-1.32 |
2021-03-31 | $-0.74 |
2020-12-31 | $-0.92 |
2020-09-30 | $-0.72 |
2020-06-30 | $-0.75 |
2020-03-31 | $-0.45 |
2019-12-31 | $-0.44 |
2019-09-30 | $-0.33 |
2019-06-30 | $-0.48 |
2019-03-31 | $-0.54 |
2018-12-31 | $-0.50 |
2018-09-30 | $-0.49 |
2018-06-30 | $-0.62 |
2018-03-31 | $-0.61 |
2017-12-31 | $-0.88 |
2017-09-30 | $-0.52 |
2017-06-30 | $-0.55 |
2017-03-31 | $-0.63 |
2016-12-31 | $-0.82 |
2016-09-30 | $-0.50 |
2016-06-30 | $-0.46 |
2016-03-31 | $-0.17 |
2015-12-31 | $3.18 |
2015-09-30 | $-0.39 |
2015-06-30 | $-3.58 |
2015-03-31 | $-1.89 |
2014-12-31 | |
2014-09-30 | $0.04 |
2014-06-30 | $-0.11 |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $19.262B | $1.697B |
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $145.222B | 26.93 |
CVS Health (CVS) | United States | $74.320B | 9.24 |
Elevance Health (ELV) | United States | $63.147B | 8.49 |
Cencora (COR) | United States | $56.296B | 19.58 |
DiDi Global (DIDIY) | China | $26.168B | 27.80 |
Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
BioMerieux (BMXMF) | France | $15.985B | 0.00 |
ICON (ICLR) | Ireland | $15.748B | 15.15 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
CochLear (CHEOY) | Australia | $13.402B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
Solventum (SOLV) | United States | $12.791B | 13.54 |
Revvity (RVTY) | United States | $12.019B | 20.68 |
Viatris (VTRS) | United States | $10.974B | 3.77 |
Avantor (AVTR) | United States | $9.547B | 13.87 |
Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
HealthEquity (HQY) | United States | $8.162B | 35.75 |
Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
Sotera Health (SHC) | United States | $3.437B | 19.53 |
Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
Organon (OGN) | United States | $2.618B | 2.78 |
Concentras Parent (CON) | United States | $2.517B | 14.55 |
GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
Progyny (PGNY) | United States | $1.972B | 43.40 |
GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
Premier (PINC) | United States | $1.747B | 13.26 |
PACS (PACS) | United States | $1.742B | 0.00 |
Ardent Health (ARDT) | United States | $1.543B | 6.58 |
Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.857B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
CareDx (CDNA) | United States | $0.715B | 11.16 |
Embecta (EMBC) | United States | $0.665B | 4.48 |
Nutex Health (NUTX) | United States | $0.532B | 8.05 |
InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
SBC Medicals (SBC) | United States | $0.505B | 0.00 |
Omada Health (OMDA) | $0.486B | 0.00 | |
LifeMD (LFMD) | United States | $0.485B | 0.00 |
So-Young (SY) | China | $0.480B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
Enhabit (EHAB) | United States | $0.349B | 28.71 |
Oncology Institute (TOI) | United States | $0.326B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
Beauty Health (SKIN) | United States | $0.231B | 0.00 |
Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
DocGo (DCGO) | United States | $0.148B | 24.17 |
Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
KindlyMD (NAKA) | United States | $0.080B | 0.00 |
Biodesix (BDSX) | United States | $0.061B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
ModivCare (MODV) | United States | $0.044B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |